{
  "id": "tokyo_guidelines_2018",
  "title": "Tokyo Guidelines 2018 for Acute Cholecystitis",
  "description": "Provides diagnostic criteria and severity grading for acute cholecystitis according to TG18 (Tokyo Guidelines 2018).",
  "category": "gastroenterology",
  "version": "2018",
  "parameters": [
    {
      "name": "murphys_sign",
      "type": "string",
      "required": true,
      "description": "Murphy's sign - Cessation of breathing during deep palpation of right upper quadrant",
      "options": ["yes", "no"]
    },
    {
      "name": "ruq_pain",
      "type": "string",
      "required": true,
      "description": "Right upper abdominal quadrant mass, pain, or tenderness",
      "options": ["yes", "no"]
    },
    {
      "name": "fever",
      "type": "string",
      "required": true,
      "description": "Fever (>38°C or >100.4°F)",
      "options": ["yes", "no"]
    },
    {
      "name": "elevated_crp",
      "type": "string",
      "required": true,
      "description": "Elevated CRP (>3 mg/dL)",
      "options": ["yes", "no"]
    },
    {
      "name": "elevated_wbc",
      "type": "string",
      "required": true,
      "description": "Elevated WBC count (>10,000/mm³)",
      "options": ["yes", "no"]
    },
    {
      "name": "imaging_findings",
      "type": "string",
      "required": true,
      "description": "Imaging findings characteristic of acute cholecystitis (e.g. pericholecystic fluid, gallstones/debris)",
      "options": ["yes", "no"]
    },
    {
      "name": "cardiovascular_dysfunction",
      "type": "string",
      "required": true,
      "description": "Cardiovascular dysfunction - Hypotension requiring treatment with dopamine ≥5 μg/kg per min or any dose of norepinephrine",
      "options": ["yes", "no"]
    },
    {
      "name": "neurological_dysfunction",
      "type": "string",
      "required": true,
      "description": "Neurological dysfunction - Decreased level of consciousness",
      "options": ["yes", "no"]
    },
    {
      "name": "respiratory_dysfunction",
      "type": "string",
      "required": true,
      "description": "Respiratory dysfunction - PaO2/FiO2 ratio <300",
      "options": ["yes", "no"]
    },
    {
      "name": "renal_dysfunction",
      "type": "string",
      "required": true,
      "description": "Renal dysfunction - Oliguria or creatinine >2.0 mg/dL",
      "options": ["yes", "no"]
    },
    {
      "name": "hepatic_dysfunction",
      "type": "string",
      "required": true,
      "description": "Hepatic dysfunction - PT-INR >1.5",
      "options": ["yes", "no"]
    },
    {
      "name": "hematological_dysfunction",
      "type": "string",
      "required": true,
      "description": "Hematological dysfunction - Platelet count <100,000/mm³",
      "options": ["yes", "no"]
    },
    {
      "name": "wbc_over_18000",
      "type": "string",
      "required": true,
      "description": "Elevated WBC count >18,000/mm³",
      "options": ["yes", "no"]
    },
    {
      "name": "palpable_mass",
      "type": "string",
      "required": true,
      "description": "Palpable tender mass in the right upper abdominal quadrant",
      "options": ["yes", "no"]
    },
    {
      "name": "duration_over_72h",
      "type": "string",
      "required": true,
      "description": "Duration of complaints >72 hours",
      "options": ["yes", "no"]
    },
    {
      "name": "marked_inflammation",
      "type": "string",
      "required": true,
      "description": "Marked local inflammation (gangrenous cholecystitis, pericholecystic abscess, hepatic abscess, biliary peritonitis, emphysematous cholecystitis)",
      "options": ["yes", "no"]
    }
  ],
  "result": {
    "name": "tokyo_guidelines_result",
    "type": "string",
    "unit": "",
    "description": "Diagnostic and severity grading result"
  },
  "interpretation": {
    "ranges": [
      {
        "criteria": "no_diagnosis",
        "stage": "Not Acute Cholecystitis",
        "description": "Entry criteria not met",
        "interpretation": "Does not meet diagnostic criteria for acute cholecystitis. Consider other diagnoses."
      },
      {
        "criteria": "suspected",
        "stage": "Suspected Acute Cholecystitis",
        "description": "Suspected diagnosis",
        "interpretation": "Meets diagnostic criteria for suspected acute cholecystitis. Further evaluation recommended."
      },
      {
        "criteria": "definite",
        "stage": "Definite Acute Cholecystitis",
        "description": "Definite diagnosis",
        "interpretation": "Meets diagnostic criteria for definite acute cholecystitis. Proceed with severity grading."
      },
      {
        "criteria": "grade_i",
        "stage": "Grade I (Mild)",
        "description": "Mild acute cholecystitis",
        "interpretation": "Mild acute cholecystitis without organ dysfunction. 1.1% 30-day mortality. Early laparoscopic cholecystectomy recommended."
      },
      {
        "criteria": "grade_ii",
        "stage": "Grade II (Moderate)",
        "description": "Moderate acute cholecystitis",
        "interpretation": "Moderate acute cholecystitis with local inflammation. 5.4% 30-day mortality. Immediate supportive care, antibiotics, and urgent cholecystectomy."
      },
      {
        "criteria": "grade_iii",
        "stage": "Grade III (Severe)",
        "description": "Severe acute cholecystitis",
        "interpretation": "Severe acute cholecystitis with organ dysfunction. 18.8% 30-day mortality. ICU admission, organ support, emergent drainage or cholecystectomy."
      }
    ]
  },
  "references": [
    "Yokoe M, Hata J, Takada T, Strasberg SM, Asbun HJ, Wakabayashi G, et al. Tokyo Guidelines 2018: diagnostic criteria and severity grading of acute cholecystitis (with videos). J Hepatobiliary Pancreat Sci. 2018 Jan;25(1):41-54. doi: 10.1002/jhbp.515.",
    "Takada T, Strasberg SM, Solomkin JS, Pitt HA, Gomi H, Yoshida M, et al. TG13: Updated Tokyo Guidelines for the management of acute cholangitis and cholecystitis. J Hepatobiliary Pancreat Sci. 2013 Jan;20(1):1-7. doi: 10.1007/s00534-012-0566-y.",
    "Gomi H, Solomkin JS, Schlossberg D, Okamoto K, Takada T, Strasberg SM, et al. Tokyo Guidelines 2018: antimicrobial therapy for acute cholangitis and cholecystitis. J Hepatobiliary Pancreat Sci. 2018 Jan;25(1):3-16. doi: 10.1002/jhbp.518."
  ],
  "formula": "Diagnostic: ≥1 item from Part A + ≥1 item from Part B (suspected) or Part A + Part B + Part C (definite). Severity: Grade III if any organ dysfunction, Grade II if any moderate criteria, Grade I if neither.",
  "notes": [
    "TG18 diagnostic criteria remain unchanged from TG13",
    "Suspected diagnosis: Part A + Part B",
    "Definite diagnosis: Part A + Part B + Part C",
    "Grade III criteria supersede Grade II criteria",
    "Early laparoscopic cholecystectomy is recommended for all grades if patient can tolerate surgery"
  ]
}